The education subgroup of APLAR Young Rheumatologists (AYR) oversee the educational activities. The education subgroup aims to improve the clinical and scientific knowledge among young rheumatologists and trainees. The first APLAR Young Rheumatologist symposium was held at Brisbane APLAR Congress 2019 and the second at the APLAR Virtual Congress 2020. AYR planned to do conduct the AYR symposium every year at the APLAR congress.
AYR has developed a working relationship with its EULAR counterpart (EMEUNET). The APLAR and EULAR collaboration look set to provide further opportunities for APLAR Young Rheumatologists (AYR) in both these organisations. There are two programs available for the AYR’s.
- APLAR-EULAR SCHOOL OF RHEUMATOLOGY (ESOR)
- APLAR-EULAR Exchange Program
The APLAR-EULAR SCHOOL OF RHEUMATOLOGY (ESOR) has already provided over one hundred AYRs from several countries the opportunities to follow world-renowned rheumatology courses of the ESOR at a concessionary rate.
The APLAR-EULAR Exchange Program promotes the international exchange of clinical and research skills, expertise, and knowledge within rheumatology. The program recognises outstanding rheumatology professional faculty in both laboratory and clinic-based research and provides exposure to the exciting work being done by colleagues overseas. This exchange program allows candidates to share knowledge, experience, and creates opportunities for collaboration.
The program supports young academic rheumatologists to travel from the Asia Pacific to Europe to experience the EULAR Annual Congress, engage in a half-day exchange program with European colleagues at the Annual Congress, and participate in a subsequent site visit at a local institution. A travel grant will be awarded upon completion of the program.
In addition to the above, the education subgroup arranged two live webinars featuring two leading rheumatologists recently. The first webinar themed: Sherlock Holmes in Axial SpA was by Prof. Denis Poddubnyy. The second was on Enthesitis: Immunopathology Update and Clinical Implications by Prof Mikkel Ostergaard.